Table 3.
Predictors of quarterly transitions along the using-to-treatment and using-to-recovery pathways
Predictor (at the beginning of the quarter) | Mean | S.D. | Using-to-treatment pathwaya,b | Using-to-recovery pathwaya,c | ||||||
---|---|---|---|---|---|---|---|---|---|---|
|
|
|||||||||
Odds ratio | 95% CI | Wald | p-value | Odds ratio | 95% CI | Wald | p-value | |||
Severity | ||||||||||
Substance Frequency Scale | 0.217 | 0.200 | 0.70 | (0.52–0.93) | −2.426 | (0.015) | 0.68 | (0.54–0.86) | −3.265 | (0.001) |
Substance Problem Scale | 5.407 | 4.855 | – | – | – | – | 0.72 | (0.56–0.92) | −2.639 | (0.008) |
Cognitive | ||||||||||
Problem Recognition Index | 28.082 | 9.356 | – | – | – | – | – | – | – | – |
Problem Orientation Index | 18.781 | 2.848 | 1.47 | (1.09–1.98) | 2.522 | (0.012) | 1.32 | (1.11–1.57) | 3.137 | (0.002) |
Desire for Help Index | 26.148 | 6.059 | 1.60 | (1.13–2.25) | 2.664 | (0.008) | – | – | – | – |
Self-Efficacy Index | 16.851 | 4.347 | – | – | – | – | 1.24 | (1.02–1.51) | 2.192 | (0.028) |
Motivation | ||||||||||
External Pressure Index | 15.121 | 4.929 | – | – | – | – | – | – | – | – |
Internal Motivation Index | 23.893 | 6.164 | – | – | – | – | – | – | – | – |
Treatment Resistance Index | 12.775 | 3.513 | – | – | – | – | – | – | – | – |
Environment | ||||||||||
Self-Help Group Participation | 7.984 | 17.863 | – | – | – | – | 1.20 | (1.03–1.41) | 2.329 | (0.020) |
Recovery Environment Risk Index | 0.286 | 0.113 | – | – | – | – | 0.79 | (0.64–0.98) | −2.177 | (0.029) |
Access Barrier Index | 18.657 | 5.944 | – | – | – | – | 0.81 | (0.68–0.97) | −2.284 | (0.022) |
Condition | ||||||||||
RMC (vs. control) | 0.464 | 1.000 | 3.22 | (1.02–10.23) | 1.986 | (0.047) | – | – | – | – |
Amount of treatment during the quarterd | 5.592 | 10.532 | n.a. | n.a. | n.a. | n.a. | 1.20 | (1.03–1.41) | 2.267 | (0.023) |
(–) Not significant at p < .05 (all others are shown).
Odds ratio (RMC/control) based on the odds of being in given state vs. continuing to be in the community using at the end of the quarter.
Based on 896 observations on 275 unique people.
Based on 1020 observations on 314 unique people.
Days of treatment during the subsequent 90-day quarter; not considered for transition to treatment by the end of the quarter; as noted in the text, the effect of RMC on transition to recovery is mediated by its ability to increase treatment participation during the quarter.